Recordati Rare Diseases

Recordati has been at the forefront of life-enhancing and life-changing medicines for 100 years. The company develops and markets treatments for rare diseases, helping unlock the full potential of life for patients with rare metabolic, cardiovascular, and endocrine conditions.

Source: https://www.recordati.com

osilodrostatIsturisa

cortisol synthesis inhibitor

Isturisa (osilodrostat) is an oral cortisol synthesis inhibitor from Recordati Rare Diseases for adults with endogenous Cushing's syndrome when surgery is not an option or has not been curative. It blocks the enzyme that makes cortisol in the adrenal glands, lowering the excess hormone that drives the disease.

Cushing's syndrome is caused by the body producing too much cortisol, a hormone made by the adrenal glands. Osilodrostat is taken by mouth and blocks

1 medicine explained